1/18
Vocabulary practice cards focusing on the enzymatic control, hormonal signalling, pathology, and comparative biology of glucose homeostasis.
Reciprocal Regulation
A regulatory mechanism in which opposing metabolic pathways or enzymes are controlled in opposite directions—when one pathway or enzyme is active, the other is inactive—preventing futile cycling.
Glycogen Synthase a
The unphosphorylated, catalytically active ("ON") form of glycogen synthase that promotes glycogen synthesis.
Glycogen Synthase b
The phosphorylated, inactive ("OFF") form of glycogen synthase produced when Protein kinase A adds a phosphate group in response to glucagon.
Glycogen Phosphorylase a
The phosphorylated, catalytically active ("ON") form of glycogen phosphorylase that catalyses glycogen breakdown into glucose-1-phosphate in response to glucagon.
Glycogen Phosphorylase b
The dephosphorylated, inactive ("OFF") form of glycogen phosphorylase resulting from the action of Protein phosphatase 1 in response to insulin.
Protein Kinase A
An enzyme activated downstream of cyclic AMP (cAMP) upon glucagon stimulation that phosphorylates both glycogen synthase (converting it to the inactive b form) and glycogen phosphorylase (converting it to the active a form).
Protein Phosphatase 1
An enzyme activated in response to insulin that hydrolyses phosphate groups (Pi) from glycogen synthase b and glycogen phosphorylase a, turning glycogen synthesis ON and glycogen degradation OFF.

Rate-Determining Step
The slowest step of a chemical reaction pathway that determines the speed (rate) at which the overall reaction proceeds; it acts like the neck of a funnel and typically serves as a major control point.
Phosphofructokinase-1 (PFK-1)
The enzyme responsible for phosphorylating fructose-6-phosphate to fructose-1,6-bisphosphate coupled to ATP hydrolysis; it represents the primary regulatory point and true rate-limiting step of glycolysis.
Allosteric Regulation
Regulation of enzyme activity caused by the binding of effector molecules to an allosteric site distinct from the active site, allowing pathways to respond to downstream intermediates and cross-pathway signals.
Blood Glucose Set Point
The homeostatic target concentration of glucose in the blood maintained through opposing hormonal regulation by insulin and glucagon, approximately 90mg/100mL.
Type-1 Diabetes Mellitus
A form of diabetes accounting for approximately 10% of cases, characterized by the destruction of pancreatic β-cells due to an autoimmune process or idiopathic etiology, leading to an absence of insulin production.
Type-2 Diabetes Mellitus
A condition accounting for approximately 90% of diabetes cases, resulting primarily from insulin resistance paired with β-cell dysfunction, influenced by obesity, sedentary lifestyle, age, diet, genetics, and inflammation.

Global Diabetes Burden
An epidemic affecting approximately 415 million people worldwide in 2015, projected to reach 642 million by 2040 and more than double by 2050, currently causing over 4 million deaths annually (9% of all global deaths).

Lep(ob/ob) and Lep(db/db) Mouse Models
Genetically obese mouse models carrying single-gene mutations in the leptin gene (Lepob/ob) or the leptin receptor gene (Lepdb/db); lack of leptin satiety signalling leads to hyperphagia and hyperglycaemia.
Bear Hibernation Metabolism
A state in which bears ingest approximately 20,000calories/day in autumn and reversibly turn insulin resistance on and off via expression changes in 8 key genes (including Akt), maintaining stable blood glucose and insulin levels all year.
Migratory Bird Lipid Loading
Pre-migratory accumulation of up to 0.15g of triglyceride per day per gram of body weight (equivalent to 10kg/day in humans) to fuel non-stop flights of up to 60h at speeds approaching 40kph.
Glucagon-Like Peptide-1 (GLP-1)
An incretin peptide hormone secreted by the ileum and large intestine in response to food that enhances insulin secretion, promotes β-cell survival, and slows gastric emptying, possessing a circulating half-life of only 2minutes.

Extendin-4
A peptide hormone discovered in Gila monster venom that shares homology with human GLP-1 but has a half-life of several hours, serving as the biological template for GLP-1 receptor agonists like semaglutide.